Vanguard Fiduciary Trust’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$86.6M Sell
1,590,943
-42,757
-3% -$2.08M 0.02% 594
2026
Q1
$70.1M Buy
+1,633,700
New +$70.2M 0.02% 648

Other funds holding EXEL

Vanguard Fiduciary Trust's EXEL Position: Q2 2026 in Review

Vanguard Fiduciary Trust reduced its Exelixis (EXEL) stake by 2.6% in Q2 2026, selling an estimated $2.08M and leaving 1,590,943 shares worth $86.6M. The position accounts for 0.02% of the portfolio, ranked #594.

Vanguard Fiduciary Trust first reported a position in EXEL in Q1 2026 and has held it in 2 quarters since. 748 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Vanguard Fiduciary Trust held 1,590,943 shares of Exelixis worth $86.6M as of Q2 2026.
  • Vanguard Fiduciary Trust sold 42,757 Exelixis shares in Q2 2026, an estimated $2.08M.
  • Exelixis made up 0.02% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #594 holding.
  • Vanguard Fiduciary Trust first reported a position in Exelixis in Q1 2026 and has held it in 2 quarters since.
  • 748 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.